SLC9A1: A Potential Drug Target and Biomarker for Na(+)/H(+) Exchanger 1

Target Name: SLC9A1

NCBI ID: G6548

SLC9A1

SLC9A1: A Potential Drug Target and Biomarker for Na(+)/H(+) Exchanger 1

Sodium channels, also known as sodium ions (Na+) channels, are essential for various physiological processes in the body. They play a crucial role in neural and muscle function, as well as in the regulation of body temperature and fluid balance. The sodium channels are also known as Na(+)/H(+) exchangers (NAE), and they are involved in the regulation of the concentration of sodium ions and protons in the body. SLC9A1, a member of the Na+/H+ exchanger (NAE) family, is a protein that is expressed in various tissues and cells in the body. It is known to play a critical role in the regulation of ion concentration in the body, and it is potential drug target and biomarker.

Purpose of SLC9A1

SLC9A1 is a member of the NAE family, which is a transmembrane protein that plays a crucial role in the regulation of ion concentration in the body. The NAE proteins are involved in the regulation of the concentration of sodium ions and protons in the body, which is essential for various physiological processes, including muscle and neural function, as well as body temperature and fluid balance. SLC9A1 is responsible for regulating the concentration of sodium ions and protons in the body, and it is essential for maintaining the proper functioning of various physiological processes.

Drug Targeting

SLC9A1 is a potential drug target, and various studies have suggested that targeting this protein may be effective in treating various neurological and cardiovascular disorders. SLC9A1 has been shown to play a role in the regulation of neural function, and it is involved in the regulation of muscle contractions. Therefore, targeting SLC9A1 with drugs that can modulate its activity may be effective in treating various neurological disorders, such as Alzheimer's disease, Parkinson's disease, and myasthenia gravis.

Biomarker

SLC9A1 is also a potential biomarker for various physiological processes in the body. The concentration of sodium ions and protons in the body is affected by various factors, including diet, exercise, and certain medical conditions. Therefore, measuring the concentration of sodium ions and protons in the body may be an effective way to diagnose and monitor various physiological processes in the body. SLC9A1 has been shown to be involved in the regulation of the concentration of sodium ions and protons in the body, and its activity may be affected by various physiological conditions, such as heart disease, diabetes, and hypertension. Therefore, measuring the concentration of SLC9A1 may be an effective way to diagnose and monitor various physiological processes in the body.

Conclusion

SLC9A1 is a protein that is involved in the regulation of the concentration of sodium ions and protons in the body. It is a potential drug target and biomarker, and its activity may be affected by various physiological conditions. Further research is needed to fully understand the role of SLC9A1 in the regulation of ion concentration in the body, as well as its potential as a drug target and biomarker.

Protein Name: Solute Carrier Family 9 Member A1

Functions: Involved in pH regulation to eliminate acids generated by active metabolism or to counter adverse environmental conditions. Major proton extruding system driven by the inward sodium ion chemical gradient. Plays an important role in signal transduction

The "SLC9A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLC9A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets